As of September 29, 2026, the three largest insider holders of EXEL are Michael Morrissey (President And Ceo, 3.37Mn shares), David Edward Johnson (Director, 1.55Mn shares), Stelios Papadopoulos (Director, 1.20Mn shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Michael Morrissey | President And Ceo | 1,362,008 | 2,004,327 | 3,366,335 | 29.8% | 19 May, 2026 |
| 2 | David Edward Johnson | Director | 0 | 1,553,262 | 1,553,262 | 13.8% | 26 Nov, 2025 |
| 3 | Stelios Papadopoulos | Director | 1,197,595 | 0 | 1,197,595 | 10.6% | 29 May, 2026 |
| 4 | Christopher J. Senner | Evp And Cfo | 952,317 | 0 | 952,317 | 8.4% | 19 May, 2026 |
| 5 | Jeffrey Hessekiel | Evp General Counsel | 693,396 | 0 | 693,396 | 6.1% | 16 May, 2025 |
| 6 | Dana Aftab | Evp, Research And Development | 594,741 | 0 | 594,741 | 5.3% | 28 May, 2026 |
| 7 | Amy C. Peterson | Evp Prod Dev Med Aff Cmo | 465,393 | 0 | 465,393 | 4.1% | 16 May, 2025 |
| 8 | Lance Willsey | Director | 424,415 | 0 | 424,415 | 3.8% | 13 May, 2022 |
| 9 | Peter Lamb | Evp, Scientific Strategy Cso | 410,958 | 0 | 410,958 | 3.6% | 16 Dec, 2022 |
| 10 | Patrick J. Haley | Evp, Commercial | 357,638 | 0 | 357,638 | 3.2% | 22 May, 2026 |
| 11 | Vicki L Goodman | Evp, Prod Dev Med Aff Cmo | 307,654 | 0 | 307,654 | 2.7% | 05 Apr, 2023 |
| 12 | Jack L Wyszomierski | Director | 284,384 | 0 | 284,384 | 2.5% | 03 Jun, 2026 |
| 13 | George Poste | Director | 127,199 | 0 | 127,199 | 1.1% | 29 May, 2026 |
| 14 | Maria C Freire | Director | 109,186 | 0 | 109,186 | 1.0% | 29 May, 2026 |
| 15 | Brenda Hefti | Svp And General Counsel | 106,762 | 0 | 106,762 | 0.9% | 19 May, 2026 |
| 16 | Vincent T Marchesi | Director | 93,989 | 0 | 93,989 | 0.8% | 27 May, 2022 |
| 17 | Jacqueline Wright | Director | 51,756 | 0 | 51,756 | 0.5% | 02 Jun, 2023 |
| 18 | Tomas J. Heyman | Director | 50,649 | 0 | 50,649 | 0.4% | 29 May, 2026 |
| 19 | Alan M Garber | Director | 35,703 | 0 | 35,703 | 0.3% | 25 Mar, 2024 |
| 20 | Bob Oliver | Director | 29,487 | 0 | 29,487 | 0.3% | 29 May, 2026 |
| 21 | Julie Smith | Director | 28,957 | 0 | 28,957 | 0.3% | 29 May, 2026 |
| 22 | Carl B Feldbaum | Director | 18,701 | 0 | 18,701 | 0.2% | 10 Feb, 2023 |
| 23 | Sue Gail Eckhardt | Director | 16,079 | 0 | 16,079 | 0.1% | 03 Jun, 2026 |
| 24 | Mary C Beckerle | Director | 16,079 | 0 | 16,079 | 0.1% | 12 Aug, 2026 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 10 Aug, 2026 | Mary C Beckerle | Director | Disposed S | 9,812 | $53.66 | $526.51K | 16,079 | Direct |
| 01 Jun, 2026 | Sue Gail Eckhardt | Director | Disposed S | 9,812 | $50.14 | $491.97K | 16,079 | Direct |
| 01 Jun, 2026 | Jack L Wyszomierski | Director | Disposed S | 3,925 | $50.55 | $198.41K | 284,384 | Direct |
| 27 May, 2026 | Maria C Freire | Director | Acquired A | 8,367 | $0.00 | $0 | 109,186 | Direct |
| 27 May, 2026 | Julie Smith | Director | Acquired A | 8,367 | $0.00 | $0 | 28,957 | Direct |
| 27 May, 2026 | Tomas J. Heyman | Director | Acquired A | 8,367 | $0.00 | $0 | 50,649 | Direct |
| 27 May, 2026 | Stelios Papadopoulos | Director | Acquired A | 8,367 | $0.00 | $0 | 1,197,595 | Direct |
| 27 May, 2026 | Jack L Wyszomierski | Director | Acquired A | 8,367 | $0.00 | $0 | 288,309 | Direct |
| 27 May, 2026 | George Poste | Director | Acquired A | 8,367 | $0.00 | $0 | 127,199 | Direct |
| 27 May, 2026 | Mary C Beckerle | Director | Acquired A | 8,367 | $0.00 | $0 | 25,891 | Direct |
| 27 May, 2026 | Sue Gail Eckhardt | Director | Acquired A | 8,367 | $0.00 | $0 | 25,891 | Direct |
| 27 May, 2026 | David Edward Johnson | Director | Acquired A | 19,133 | $0.00 | $0 | 19,133 | Direct |
| 27 May, 2026 | Bob Oliver | Director | Acquired A | 8,367 | $0.00 | $0 | 29,487 | Direct |
| 26 May, 2026 | Dana Aftab | Evp, Research And Development | Disposed S | 43,451 | $50.35 | $2.19Mn | 594,741 | Direct |
| 20 May, 2026 | Patrick J. Haley | Evp, Commercial | Disposed S | 32,110 | $49.81 | $1.60Mn | 357,638 | Direct |
| 15 May, 2026 | Patrick J. Haley | Evp, Commercial | Disposed F | 33,265 | $51.10 | $1.70Mn | 389,748 | Direct |
| 15 May, 2026 | Dana Aftab | Evp, Research And Development | Disposed F | 30,578 | $51.10 | $1.56Mn | 638,192 | Direct |
| 15 May, 2026 | Christopher J. Senner | Evp And Cfo | Disposed F | 40,892 | $51.10 | $2.09Mn | 987,218 | Direct |
| 15 May, 2026 | Michael Morrissey | President And Ceo | Disposed F | 128,497 | $51.10 | $6.57Mn | 1,486,055 | Direct |
| 15 May, 2026 | Brenda Hefti | Svp And General Counsel | Disposed F | 6,411 | $51.10 | $327.60K | 113,387 | Direct |